Zynex Total Assets 2010-2025 | ZYXI

Zynex total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
Zynex Annual Total Assets
(Millions of US $)
2024 $122
2023 $137
2022 $116
2021 $133
2020 $72
2019 $28
2018 $19
2017 $9
2016 $4
2015 $4
2014 $7
2013 $17
2012 $26
2011 $22
2010 $16
2009 $12
Zynex Quarterly Total Assets
(Millions of US $)
2025-03-31 $106
2024-12-31 $122
2024-09-30 $126
2024-06-30 $122
2024-03-31 $126
2023-12-31 $137
2023-09-30 $151
2023-06-30 $153
2023-03-31 $111
2022-12-31 $116
2022-09-30 $115
2022-06-30 $120
2022-03-31 $132
2021-12-31 $133
2021-09-30 $91
2021-06-30 $84
2021-03-31 $70
2020-12-31 $72
2020-09-30 $65
2020-06-30 $37
2020-03-31 $33
2019-12-31 $28
2019-09-30 $25
2019-06-30 $22
2019-03-31 $19
2018-12-31 $19
2018-09-30 $13
2018-06-30 $11
2018-03-31 $9
2017-12-31 $9
2017-09-30 $6
2017-06-30 $4
2017-03-31 $4
2016-12-31 $4
2016-09-30 $5
2016-06-30 $4
2016-03-31 $4
2015-12-31 $4
2015-09-30 $5
2015-06-30 $5
2015-03-31 $6
2014-12-31 $7
2014-09-30 $10
2014-06-30 $11
2014-03-31 $16
2013-12-31 $17
2013-09-30 $23
2013-06-30 $24
2013-03-31 $25
2012-12-31 $26
2012-09-30 $26
2012-06-30 $25
2012-03-31 $24
2011-12-31 $22
2011-09-30 $21
2011-06-30 $19
2011-03-31 $17
2010-12-31 $16
2010-09-30 $15
2010-06-30 $13
2010-03-31 $14
2009-12-31 $12
2009-09-30 $12
2009-06-30 $12
2009-03-31 $12
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.069B $0.192B
Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $228.771B 27.51
Boston Scientific (BSX) United States $153.093B 38.33
Stryker (SYK) United States $149.084B 31.17
EssilorLuxottica (ESLOY) France $130.144B 0.00
Medtronic (MDT) Ireland $114.429B 16.22
Lonza Group Ag (LZAGY) Switzerland $49.231B 0.00
Haleon (HLN) United Kingdom $43.710B 24.95
ResMed (RMD) United States $36.952B 27.75
GE HealthCare Technologies (GEHC) United States $34.062B 16.17
Agilent Technologies (A) United States $32.082B 20.92
Terumo (TRUMY) Japan $24.207B 31.44
Koninklijke Philips (PHG) Netherlands $23.216B 16.29
Insulet (PODD) United States $20.408B 80.11
Zimmer Biomet Holdings (ZBH) United States $18.604B 11.95
Baxter (BAX) United States $14.497B 10.82
Smith & Nephew SNATS (SNN) United Kingdom $12.846B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.731B 23.42
Lantheus Holdings (LNTH) United States $5.622B 14.18
Perrigo (PRGO) Ireland $3.719B 9.43
Prestige Consumer Healthcare (PBH) United States $3.714B 16.59
Haemonetics (HAE) United States $3.585B 16.33
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.358B 27.90
ICU Medical (ICUI) United States $3.113B 22.96
QuidelOrtho (QDEL) United States $1.890B 13.00
LeMaitre Vascular (LMAT) United States $1.858B 41.53
AtriCure (ATRC) United States $1.512B 0.00
Acuren (TIC) United States $1.407B 0.00
Green Thumb Industries (GTBIF) United States $1.245B 28.00
Phibro Animal Health (PAHC) United States $1.239B 15.83
AdaptHealth (AHCO) United States $1.205B 12.23
Neogen (NEOG) United States $1.079B 13.81
BioLife Solutions (BLFS) United States $0.994B 0.00
InMode (INMD) Israel $0.901B 9.08
Kestra Medical Technologies (KMTS) United States $0.836B 0.00
Curaleaf Holdings (CURLF) Canada $0.670B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.660B 0.00
Owens & Minor (OMI) United States $0.600B 4.98
Evolus (EOLS) United States $0.598B 0.00
Tilray Brands (TLRY) Canada $0.597B 0.00
CeriBell (CBLL) United States $0.569B 0.00
Valneva SE (VALN) France $0.549B 0.00
Surmodics (SRDX) United States $0.448B 0.00
SNDL (SNDL) Canada $0.397B 0.00
Capricor Therapeutics (CAPR) United States $0.328B 0.00
VAREX IMAGING (VREX) United States $0.318B 11.71
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Sanuwave Health (SNWV) United States $0.285B 0.00
Quanterix (QTRX) United States $0.274B 0.00
Viemed Healthcare (VMD) United States $0.262B 22.07
Cresco Labs (CRLBF) United States $0.258B 0.00
Cerus (CERS) United States $0.258B 0.00
Aurora Cannabis (ACB) Canada $0.252B 74.83
ZimVie (ZIMV) United States $0.246B 11.19
Sanara MedTech (SMTI) United States $0.242B 0.00
OraSure Technologies (OSUR) United States $0.233B 0.00
Brainsway (BWAY) Israel $0.231B 61.00
Biote (BTMD) United States $0.216B 6.06
Omeros (OMER) United States $0.212B 0.00
Canopy Growth (CGC) Canada $0.200B 0.00
Verano Holdings (VRNOF) United States $0.199B 0.00
Organigram Global (OGI) Canada $0.192B 0.00
High Tide (HITI) Canada $0.188B 0.00
Utah Medical Products (UTMD) United States $0.182B 14.80
TriSalus Life Sciences (TLSI) United States $0.179B 0.00
Vireo Growth (VREOF) United States $0.155B 0.00
Exagen (XGN) United States $0.144B 0.00
FitLife Brands (FTLF) United States $0.124B 15.25
TerrAscend (TSNDF) Canada $0.107B 0.00
Jin Medical (ZJYL) China $0.100B 0.00
Fonar (FONR) United States $0.099B 12.80
MacroGenics (MGNX) United States $0.094B 0.00
Quipt Home Medical (QIPT) United States $0.087B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.085B 0.00
Veru (VERU) United States $0.085B 0.00
Jushi Holdings (JUSHF) United States $0.080B 0.00
Apyx Medical (APYX) United States $0.077B 0.00
Agape ATP (ATPC) $0.069B 0.00
InterCure (INCR) Israel $0.068B 0.00
Cytosorbents (CTSO) United States $0.064B 0.00
ImmuCell (ICCC) United States $0.057B 0.00
United-Guardian (UG) United States $0.042B 14.41
Modular Medical (MODD) United States $0.038B 0.00
Nephros (NEPH) United States $0.037B 50.43
Rockwell Medical (RMTI) United States $0.037B 0.00
Safety Shot (SHOT) United States $0.032B 0.00
Allurion Technologies (ALUR) United States $0.024B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
INLIF (INLF) $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
IM Cannabis (IMCC) Canada $0.013B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00